OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A PSD-95 peptidomimetic mitigates neurological deficits in a mouse model of Angelman syndrome
Kara A. Lau, Xin Yang, Mengia S. Rioult-Pedotti, et al.
Progress in Neurobiology (2023) Vol. 230, pp. 102513-102513
Closed Access | Times Cited: 16

Showing 16 citing articles:

Targeting the postsynaptic scaffolding protein PSD-95 enhances BDNF signaling to mitigate depression-like behaviors in mice
Xin Shi, Xiaozhong Zhou, Gang Chen, et al.
Science Signaling (2024) Vol. 17, Iss. 834
Open Access | Times Cited: 13

Targeting TrkB–PSD-95 coupling to mitigate neurological disorders
Xin Yang, Yu‐Wen Alvin Huang, John Marshall
Neural Regeneration Research (2024) Vol. 20, Iss. 3, pp. 715-724
Open Access | Times Cited: 6

Novel peptidomimetic compounds attenuate hypoxic-ischemic brain injury in neonatal rats
Xiaodi Chen, Brynn Kroke, Jun Ni, et al.
Experimental Neurology (2025) Vol. 386, pp. 115151-115151
Closed Access

Syn3, a newly developed cyclic peptide and BDNF signaling enhancer, ameliorates retinal ganglion cell degeneration in diabetic retinopathy
Keran Li, Meng-Jia Huan, Jin Yao, et al.
Protein & Cell (2024) Vol. 15, Iss. 11, pp. 858-865
Open Access | Times Cited: 3

Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 3

Structure‐based design of peptidomimetic inhibitors of PSD‐95 with improved affinity for the PDZ3 domain
Mandar T. Naik, Nandita Naik, Ye Hu, et al.
FEBS Letters (2023) Vol. 598, Iss. 2, pp. 233-241
Closed Access | Times Cited: 7

Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model
Emily Z. Huie, Xin Yang, Mengia S. Rioult-Pedotti, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 2

Drug Treatments for Neurodevelopmental Disorders: Targeting Signaling Pathways and Homeostasis
Walter E. Kaufmann, Skylar Luu, Dejan B. Budimirovic
Current Neurology and Neuroscience Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 2

Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes
Xin Yang, Julia C. Duckhorn, John Marshall, et al.
Experimental Neurology (2024) Vol. 379, pp. 114869-114869
Closed Access | Times Cited: 1

Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model
Emily Z. Huie, Xin Yang, Mengia S. Rioult-Pedotti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Prenatal exposure of azadiradione leads to developmental disabilities
Sudipta Jana, Sagarika Das, Bhaskarjyoti Giri, et al.
Research Square (Research Square) (2024)
Open Access

Precision medicine in Angelman syndrome
Lena Manssen, Ilona Krey, Janina Gburek‐Augustat, et al.
Neuropediatrics (2024)
Closed Access

Prenatal Exposure to Azadiradione Leads to Developmental Disabilities
Sudipta Jana, Sagarika Das, Bhaskarjyoti Giri, et al.
Molecular Neurobiology (2024)
Closed Access

CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice
Stine Juul Gauger, Maria E. K. Lie, Ilse Wallaard, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 136, Iss. 1
Closed Access

Structure-based development of new cyclic compounds targeting PSD-95 PDZ3 domain
Mandar T. Naik, Nandita Naik, Tony Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Page 1

Scroll to top